
浏览全部资源
扫码关注微信
1.400038 重庆,陆军军医大学(第三军医大学):附属第一医院血管外科
2.400038 重庆,陆军军医大学(第三军医大学):基础医学部生物化学与分子生物学教研室
[郝迎学,E-mail: haoyingxue@hotmail.comHAO Yingxue, E-mail: haoyingxue@hotmail.com
收稿:2019-01-07,
修回:2020-02-11,
纸质出版:2020-05-30
移动端阅览
孙伟, 郝迎学, 张荣杰, 等. 高迁移率族蛋白A2促进胃癌细胞侵袭转移及其可能机制[J]. 第三军医大学学报, 2020,42(10):1028-1034.
Wei SUN, Yingxue HAO, Rongjie ZHANG, et al. Promotive effect and possible mechanism of high-mobility group protein A2 on invasion and metastasis of gastric cancer cells[J]. Journal of Third Military Medical University, 2020, 42(10): 1028-1034.
孙伟, 郝迎学, 张荣杰, 等. 高迁移率族蛋白A2促进胃癌细胞侵袭转移及其可能机制[J]. 第三军医大学学报, 2020,42(10):1028-1034. DOI: 10.16016/j.1000-5404.202001046.
Wei SUN, Yingxue HAO, Rongjie ZHANG, et al. Promotive effect and possible mechanism of high-mobility group protein A2 on invasion and metastasis of gastric cancer cells[J]. Journal of Third Military Medical University, 2020, 42(10): 1028-1034. DOI: 10.16016/j.1000-5404.202001046.
目的
2
观察高迁移率族蛋白A2(high-mobility group protein A2,HMGA2)在胃癌组织中的表达及与临床病理特征和预后的关系,探讨HMGA2调控胃癌细胞侵袭和增殖的作用及机制。
方法
2
利用TCGA数据库、GTEx数据库及生物信息学分析工具(GEPIA、KM plotter)对HMGA2 mRNA在胃癌中的表达及患者生存时间进行分析。并利用免疫组化检测HMGA2蛋白在胃癌及癌旁组织的表达,分析HMGA2表达与胃癌临床病理学参数的相关性及对预后的影响。在MGC-803细胞中敲低HMGA2,在SGC-7901细胞中过表达HMGA2,并利用平板克隆实验、transwell实验分别检测细胞增殖、侵袭能力的变化。在过表达HMGA2的细胞中敲低Snail1,检测细胞侵袭能力变化,Western Blot检测细胞中HMGA2及EMT标志物的表达变化。
结果
2
生物信息学分析发现胃癌组织中HMGA2 mRNA表达相较于正常胃组织显著增加(
P
<
0.05)。免疫组化显示,与癌旁组织相比,胃癌组织中HMGA2蛋白表达量显著升高
且与TNM分期、淋巴结转移以及生存率等相关。HMGA2高表达的胃癌患者,总生存期及无复发生
存期明显缩短(
P
<
0.05)。敲低HMGA2后,MGC-803细胞的增殖和侵袭能力降低(
P
<
0.05);过表达HMGA2后SGC-7901细胞的增殖和侵袭能力升高(
P
<
0.05)。在过表达HMGA2的SGC-7901细胞中,敲低Snail1表达,细胞侵袭能力明显降低(
P
<
0.05),且E-cadherin的表达升高,N-cadherin和Vimentin的表达降低。
结论
2
HMGA2高表达与胃癌患者的不良预后相关,其可能通过调控Snail1促进胃癌细胞侵袭转移。
Objective
2
To detect the expression of high-mobility group protein A2 (HMGA2) in gastric cancer tissues
investigate its relationship with clinicopathological features and prognosis
and explore its role and underlying mechanism in regulating the invasion and proliferation of gastric cancer cells.
Methods
2
TCGA database
GTEx database and bioinformatics analysis tools (GEPIA
KM plotter) were used to analyze the expression of HMGA2 gene in gastric cancer and the survival time of patients. The expression of HMGA2 protein in gastric cancer and adjacent tissues was detected by immunohistochemistry
and the correlation between HMGA2 expression and the clinicopathological parameters and its effect on prognosis of gastric cancer patients were analyzed. After HMGA2 was knocked down in gastric cancer cell line MGC-803
and overexpressed in gastric cancer cell line SGC-7901
plate cloning and transwell assay were used to detect the proliferation and invasion ability
respectively. The invasion ability was detected again in the HMGA2 overexpressed SGC-7901 cells after knockdown of Snail1. Western blotting was employed to measure the expression changes of HMGA2 and epithelial to mesenchymal transition (EMT) markers in the cells.
Results
2
The bioinformatics analysis showed that the mRNA expression of HMGA2 was significantly increased in gastric cancer tissues compared with normal gastric tissues (
P
<
0.05). Immunohistochemistry also indicated that the protein level of HMGA2 was obviously high
er in gastric cancer tissues than para-cancer tissues
and it was associated with TNM staging
lymph node metastasis and survival rate. The gastric cancer patients with high HMGA2 expression had statistically shorter total survival and relapse-free survival (
P
<
0.05). Knockdown of HMGA2 resulted in decreased proliferation and invasion ability in MGC-803 cells decreased (
P
<
0.05)
while its overexpression led to enhanced proliferation and invasion ability in SGC-7901 cells (
P
<
0.05). However
knocking down Snail1 would cause the invasion of HMGA2-overexpressed SGC-7901 cells reduced (
P
<
0.05)
and the expression level of E-cadherin up-regulated and those of N-cadherin and Vimentin down-regulated.
Conclusion
2
High HMGA2 expression is associated with poor prognosis of gastric cancer patients
and it may promote invasion and metastasis of gastric cancer cells by regulating Snail1.
BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
KIM G H, LIANG P S, BANG S J, et al . Screening and surveillance for gastric cancer in the United States: Is it needed?[J ] . Gastrointest Endosc, 2016, 84(1): 18-28. DOI: 10.1016/j.gie.2016.02.028.
SGARRA R, RUSTIGHI A, TESSARI M A, et al . Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer[J ] . FEBS Lett, 2004, 574(1/2/3): 1-8. DOI: 10.1016/j.febslet.2004.08.013.
WOOD L J, MAHER J F, BUNTON T E, et al . The oncogenic properties of the HMG-I gene family[J ] . Cancer Res, 2000, 60(15): 4256-4261.
LEE J, HA S, JUNG C K, et al . High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition[J ] . Int J Oncol, 2015, 46(6): 2431-2438. DOI: 10.3892/ijo.2015.2947.
HINDRIKSEN S, BIJLSMA M F. Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors[J]. Cancers, 2012, 4(4): 989-1035. DOI: 10.3390/cancers4040989.
FEDELE M, FUSCO A. Role of the high mobility group A proteins in the regulation of pituitary cell cycle[J]. J Mol Endocrinol, 2010, 44(6): 309-318. DOI: 10.1677/JME-09-0178.
PARISI S, PISCITELLI S, PASSARO F, et al . HMGA proteins in stemnes s and differentiation of embryonic and adult stem cells[J ] . Int J Mol Sci, 2020, 21(1): E362. DOI: 10.3390/ijms21010362.
LANGELOTZ C, SCHMID P, JAKOB C, et al . Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic Indicator for survival in metastatic breast cancer[J ] . Br J Cancer, 2003, 88(9): 1406-1410. DOI: 10.1038/sj.bjc.6600935.
MEYER B, LOESCHKE S, SCHULTZE A, et al . HMGA2 overexpression in non-small cell lung cancer[J ] . Mol Carcinog, 2007, 46(7): 503-511. DOI: 10.1002/mc.20235.
MOTOYAMA K, INOUE H, NAKAMURA Y, et al . Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family[J ] . Clin Cancer Res, 2008, 14(8): 2334-2340. DOI: 10.1158/1078-0432.CCR-07-4667.
HUANG M L, CHEN C C, CHANG L C. Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer[J]. Int J Colorectal Dis, 2009, 24(11): 1281-1286. DOI: 10.1007/s00384-009-0770-7.
WATANABE S, UEDA Y, AKABOSHI S, et al . HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells[J ] . Am J Pathol, 2009, 174(3): 854-868. DOI: 10.2353/ajpath.2009.080523.
WU J J, LIU Z J, SHAO C S, et al . HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes[J ] . Cancer Res, 2011, 71(2): 349-359. DOI: 10.1158/0008-5472.CAN-10-2550.
ZHA L, ZHANG J, TANG W X, et al . HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer[J ] . Dig Dis Sci, 2013, 58(3): 724-733. DOI: 10.1007/s10620-012-2399-6.
DONG J Q, WANG R, REN G, et al . HMGA2-FOXL2 Axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer[J ] . Clin Cancer Res, 2017, 23(13): 3461-3473. DOI: 10.1158/1078-0432.CCR-16-2180.
WANG Y F, SHI J, CHAI K Q, et al . The role of snail in EMT and tumorigenesis[J ] . Curr Cancer Drug Targets, 2013, 13(9): 963-972. DOI: 10.2174/15680096113 136660102.
YU S T, ZHANG Y Q, LI Q, et al . CLDN6 promotes tumor progression through the YAP1-snail1 Axis in gast ric cancer[J ] . Cell Death Dis, 2019, 10(12): 949. DOI: 10.1038/s41419-019-2168-y.
GAN L, LV L, LIAO S. Long non-coding RNA H19 regulates cell growth and metastasis via the miR-22-3p/Snail1 axis in gastric cancer. Int J Oncol. 2019;54(6): 2157-2168. DOI: 10.3892/ijo.2019.4773
ZOU S Y, MA C Y, YANG F H, et al . FBXO31 suppresses gastric cancer EMT by targeting Snail1 for proteasomal degradation[J ] . Mol Cancer Res, 2018, 16(2): 286-295. DOI: 10.1158/1541-7786.MCR-17-0432.
THUAULT S, VALCOURT U, PETERSEN M, et al . Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition[J ] . J Cell Biol, 2006, 174(2): 175-183. DOI: 10.1083/jcb.200512110.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621